HCAT
Health Catalyst, Inc.NASDAQHealthcare$1.17+0.86%ClosedMarket Cap: $86.1M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.33
P/S
0.27
EV/EBITDA
14.27
DCF Value
$16.24
FCF Yield
-5.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
33.5%
Operating Margin
-11.6%
Net Margin
-57.2%
ROE
-54.7%
ROA
-35.4%
ROIC
-8.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $74.7M | -10.9% | $38.7M | $-91.0M | $-1.28 | — |
| FY 2025 | $311.1M | 33.5% | $-36.1M | $-178.0M | $-2.55 | — |
| Q3 2025 | $76.3M | 49.5% | $-17.5M | $-22.2M | $-0.32 | — |
| Q2 2025 | $80.7M | 47.4% | $-37.1M | $-41.0M | $-0.59 | — |
| Q1 2025 | $79.4M | 45.6% | $-20.2M | $-23.7M | $-0.35 | — |
| Q4 2024 | $79.6M | 43.6% | $-17.5M | $-20.7M | $-0.33 | — |
| FY 2024 | $306.6M | 45.9% | $-69.8M | $-69.5M | $-1.15 | — |
| Q3 2024 | $76.4M | 44.6% | $-13.7M | $-14.7M | $-0.24 | — |
| Q2 2024 | $75.9M | 47.2% | $-15.8M | $-13.5M | $-0.23 | — |
| Q1 2024 | $74.7M | 48.5% | $-22.8M | $-20.6M | $-0.35 | — |
| Q4 2023 | $75.1M | 40.6% | $-32.8M | $-30.3M | $-0.53 | — |
| FY 2023 | $295.9M | 44.5% | $-126.9M | $-118.1M | $-2.09 | — |